PDAPP transgenic amyloid model ( APP V717F Indiana)
Progressive appearance of AD-type neuropathology: thioflavin S-positive extracellular Aβ deposits, neuritic plaques, synaptic loss, astrogliosis, and microgliosis; the V717F (Indiana) mutation increases the Aβ42/Aβ40 ratio.
Experimental animals
- Age
- 18 months of age
- Tissue
- brain
Model identity
- Model name
- PDAPP transgenic amyloid model (APP V717F Indiana)
- Species
- mouse
- Taxonomy ID
- 10090
- Genetic background
- The original PDAPP founder population used a Swiss Webster×B6D2F1 (C57BL/6×DBA/2) mixed genetic background.
- Genotype / zygosity
- High expression of human APP V717F (Indiana) mutation
Biological characteristics
- Research questions
- Plaque formation and progression in the first amyloid model pedigree; pathological study driven by Aβ42 ratio
- Limitations
- The literature reference model does not represent what the company actually possesses, supplies, or performs quality control on; the transgenic overexpression paradigm and the full-spectrum pathology of human AD exhibit species and mechanistic differences;
References
- PMID:7845465; DOI:10.1038/373523a0; Nature 1995 · DOI: 10.1038/373523a0
- PMID:37887303; DOI:10.3390/cells12202459; PMC10605533; Cells 2023 (review of AD mammalian models) · DOI: 10.3390/cells12202459
- NCBI Taxonomy database record 10090: Mus musculus (house mouse), species rank. · https://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?id=10090
- Chen G, Chen KS, Kobayashi D, et al. Active β-Amyloid Immunization Restores Spatial Learning in PDAPP Mice Displaying Very Low Levels of β-Amyloid. J Neurosci. 2007;27(10):2654–2662. DOI:10.1523/JNEUROSCI.3710-06.2007; PMID:17344403. Materials and Methods, Subjects: PDAPP founder background. · DOI: 10.1523/JNEUROSCI.3710-06.2007